News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Litigation Wntangling Nucleonics Inc. Resolved; Assets Sold
January 26, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Litigation that last year pitted a Montgomery County biotechnology company’s former top researchers against the firm’s managers has been settled, according to records filed at the U.S. District Court in Philadelphia.
Twitter
LinkedIn
Facebook
Email
Print
Legal
MORE ON THIS TOPIC
Legal
Kennedy’s Vaccine Policy Overhaul Stymied by Federal Judge
March 17, 2026
·
3 min read
·
Tristan Manalac
Government
As Midterms Loom, White House Cracks Down on RFK Jr.’s Vaccine Policies—but MAHA Resists
March 16, 2026
·
4 min read
·
Tristan Manalac
Rare diseases
Senator Ron Johnson Launches Investigation Into FDA Rare Disease Rejections
March 10, 2026
·
3 min read
·
Heather McKenzie
Opinion
Direct-to-Consumer Drugs Are Not a Panacea for High Costs
March 6, 2026
·
4 min read
·
Michael Grosberg